Brief: Artrya Submits 510(K) Application To US FDA
30/09/2024 02:23
Sept 30 (Reuters) - Artrya Ltd AYA.AX :
* SUBMITS 510(K) APPLICATION TO US FDA
* APPLICATION TO FDA FOR REGULATORY APPROVAL OF ITS SALIX
CORONARY
ANATOMY PRODUCT
Source text for Eikon: ID:nASX3QsB4y
Further company coverage: AYA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Artrya
See all newsAustralia's Artrya soars on bagging fourth US commercial customer
Brief: Artrya Reports FY Loss From Ordinary Activities After Tax Attributable A$25.2 Million
Brief: Artrya Appoints Richard Jarvis As CFO
Australia's Artrya at three-week peak on deal with US co
Brief: Artrya To Raise About A$75 Mln Via Placement At Issue Price Of A$2.05 Per Share